• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER, INC. REFOBACIN BONE CEMENT; BONE CEMENT, ANTIBIOTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER, INC. REFOBACIN BONE CEMENT; BONE CEMENT, ANTIBIOTIC Back to Search Results
Lot Number 13CA12607
Patient Problem Pain (1994)
Event Date 01/30/2024
Event Type  Injury  
Event Description
Clinical adverse event received for anterior knee pain.Event is not serious and is considered mild.Event is possibly related to both device and procedure.This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REFOBACIN BONE CEMENT
Type of Device
BONE CEMENT, ANTIBIOTIC
Manufacturer (Section D)
ZIMMER, INC.
MDR Report Key18876982
MDR Text Key337576250
Report NumberMW5152588
Device Sequence Number1
Product Code MBB
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Unknown
Type of Report Initial
Report Date 03/08/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/08/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Lot Number13CA12607
Patient Sequence Number1
-
-